Sutro Biopharma (STRO) Other financing activities (2017 - 2025)
Sutro Biopharma (STRO) reported Other financing activities of -$1000.0 for Q4 2025, up 100.0% on a YoY basis from -$500.0 in Q4 2024, and up 99.59% sequentially from -$245000.0 in Q3 2025.
Sutro Biopharma (STRO) Other financing activities (2017 - 2025) Analysis & Trends
Sutro Biopharma (STRO) has 9 years of Other financing activities data on file, last reported at -$1000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other financing activities rose 100.0% year-over-year to -$1000.0; the trailing twelve-month figure through Sep 2025 stood at -$71.3 million (down 10.7% YoY), and the FY2024 full-year result was $271000.0, down 13.69% from the prior year.
- Other financing activities rose to -$1000.0 in Q4 2025, from -$245000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $135.9 million in Q3 2023 to a low of -$135.9 million in Q4 2023.
- A 5-year average of $196352.9 and a median of $246000.0 in 2025 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities tumbled 5746.81% in 2022 and soared 9220.05% in 2024, its largest moves.
- Tracing STRO's Other financing activities over 5 years: stood at $720000.0 in 2021, then plunged by 5746.81% to -$40.7 million in 2022, then slumped by 234.25% to -$135.9 million in 2023, then soared by 47.57% to -$71.3 million in 2024, then soared by 100.0% to -$1000.0 in 2025.
- Business Quant data shows STRO's Other financing activities at -$1000.0 in Q4 2025, -$245000.0 in Q3 2025, and $246000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | -245,000.00 |
| Sep 30, 2025 | -245,000.00 |
| Mar 31, 2025 | 246,000.00 |
| Mar 31, 2025 | 246,000.00 |
| Dec 31, 2024 | -71.26 Mn |
| Dec 31, 2024 | -71.26 Mn |
| Jun 30, 2024 | 71.41 Mn |
| Jun 30, 2024 | 71.41 Mn |
| Mar 31, 2024 | 117,000.00 |
| Mar 31, 2024 | 117,000.00 |
| Dec 31, 2023 | -135.89 Mn |
| Dec 31, 2023 | -135.89 Mn |
| Sep 30, 2023 | 135.89 Mn |
| Sep 30, 2023 | 135.89 Mn |
| Jun 30, 2023 | -783,000.00 |
| Jun 30, 2023 | -783,000.00 |
| Mar 31, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.10 Mn |